Stephen Parker

Stephen Barry Parker is the founder of UK Stem Cell Foundation.
Current roles include Executive Chairman at Sareum Holdings Plc since 2024, Non-Executive Chairman at Biodexa Pharmaceuticals Plc since 2022, Non-Executive Chairman at Drishti Discoveries Ltd. since 2021, Director at Sareum Ltd., Director at Sp2 Consulting Ltd., Non-Executive Director at Eternans Ltd. since 2019, Director at Sp2 Asset Management Ltd. since 2018, and Partner at Celtic Pharma Management LP since 2005.
Former roles include Non-Executive Chairman at Argent BioPharma Ltd. from 2019 to 2023, Non-Executive Chairman at Physiomics Plc from 2004 to 2005, Chairman at Ah Animal Healthcare Ltd., Chairman at Liverpool Chirochem Ltd. from 2017 to 2018, Director at Xenova Group Plc, Independent Non-Executive Director at Silence Therapeutics Plc from 2013 to 2019, Director at Houlihan Lokey Advisory Ltd., Director at Celtic Pharma Development UK Plc, Director at Novacta Biosystems Ltd., Director at PBB Devices Ltd., Director at Xenova Ltd., Non-Executive Director at Gammadelta Therapeutics Ltd., Director at Albucasis Ltd. from 2013 to 2019, Director at Celtic Pharma GP Ltd., Principal at Apax Partners LLP, Principal at Celtic Pharma Holdings Advisors LLP, Consultant at PA Consulting Group Holdings Ltd., Principal at Warburg Group Plc, Chief Financial Officer at Oxford GlycoSciences Plc in 2002, Principal at Barings Plc, Partner at Beehive Capital LLP, and Head-Partner Network, Research & Development at Bedford Royalties Ltd. Education includes a doctorate from the University of Oxford, an undergraduate degree from the University of East Anglia, and an MBA from Bayes Business School.